55 results
8-K
EX-1.1
loxfeen0uyr4izm81a4
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
424B5
3j9sz58
15 Nov 23
Prospectus supplement for primary offering
4:49pm
424B3
5gmuj6f zqi28s
13 Jul 23
Prospectus supplement
4:32pm
424B5
u7hx68
17 May 23
Prospectus supplement for primary offering
4:25pm
8-K
EX-10.1
z7bvpa21pa wv94ywewe
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
PRE 14A
4wvhp5o x3rkrjjgb6c
17 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
p0qp8npj rubhx
14 Nov 22
Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
7:11am